Avatrombopag is indicated for:
Irrespective of gender only Adults (18 - 65 years old)
Avatrombopag is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).
For this indication, the medical literature mentions below treatments (click for details):
Irrespective of gender only Adults (18 - 65 years old)
Avatrombopag is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
For this indication, the medical literature mentions below treatments (click for details):